These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 17057945

  • 1. Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.
    Hassin-Baer S, Levy Y, Langevitz P, Nakar S, Ehrenfeld M.
    Clin Rheumatol; 2007 May; 26(5):743-7. PubMed ID: 17057945
    [Abstract] [Full Text] [Related]

  • 2. Incidence of thromboembolic events in patients with primary Sjögren's syndrome.
    Haga HJ, Jacobsen EM, Peen E.
    Scand J Rheumatol; 2008 May; 37(2):127-9. PubMed ID: 18415770
    [Abstract] [Full Text] [Related]

  • 3. Decrease in the ratio of polyreactive IgG titers with IgG concentration is associated with long-term complications of primary Sjögren's syndrome.
    Argyropoulou OD, Gunti S, Kapsogeorgou EK, Notkins AL, Tzioufas AG.
    Clin Exp Rheumatol; 2018 May; 36 Suppl 112(3):239-240. PubMed ID: 30156547
    [No Abstract] [Full Text] [Related]

  • 4. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
    Cervera R, García-Carrasco M, Font J, Ramos M, Reverter JC, Muñoz FJ, Miret C, Espinosa G, Ingelmo M.
    Clin Exp Rheumatol; 1997 May; 15(4):361-5. PubMed ID: 9272295
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies against interferon-γ reduce the frequency of pulmonary fibrosis and concentration of C-reactive protein in patients with primary Sjögren's syndrome.
    Yang L, Bai L, Wei F, Pang C, Wang X, Wang Y, Liu X.
    Mod Rheumatol; 2015 Mar; 25(2):325-7. PubMed ID: 25036231
    [No Abstract] [Full Text] [Related]

  • 6. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
    Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR.
    Scand J Rheumatol; 2005 Mar; 34(5):383-6. PubMed ID: 16234186
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
    Waterman SA, Gordon TP, Rischmueller M.
    Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
    [Abstract] [Full Text] [Related]

  • 8. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ, Kelder JC.
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P, Chizzolini C, Chofflon M, Roux-Lombard P, Lalive PH, Picard F.
    Eur Neurol; 2007 Mar; 57(3):166-71. PubMed ID: 17213724
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prevalence of antiphospholipid antibodies in patients with primary Sjögren's syndrome].
    Puszczewicz M, Zimmermann-Górska I, Białkowska-Puszczewicz G.
    Pol Arch Med Wewn; 2006 May; 115(5):414-6. PubMed ID: 17195353
    [Abstract] [Full Text] [Related]

  • 12. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A, Kiss E, Sas A, Szegedi G, Zeher M.
    Orv Hetil; 2005 Dec 11; 146(50):2533-8. PubMed ID: 16440498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome.
    Jedryka-Goral A, Jagiello P, D'Cruz DP, Maldykowa H, Khamashta MA, Hughes GR, Swana GT, Luft S.
    Ann Rheum Dis; 1992 Jul 11; 51(7):889-91. PubMed ID: 1632664
    [Abstract] [Full Text] [Related]

  • 16. Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren's syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature.
    Saeki T, Nakajima A, Ito T, Takata T, Imai N, Yoshita K, Kabasawa H, Yamazaki H, Narita I.
    Mod Rheumatol; 2018 Sep 11; 28(5):897-900. PubMed ID: 27142563
    [Abstract] [Full Text] [Related]

  • 17. Anti-cardiolipin autoantibodies and pulmonary embolism. A case for a common cause.
    Ulvestad E, Kanestrøm A, Tengnér P, Gjerde S, Sundal J, Haga HJ.
    Scand J Rheumatol; 2000 Sep 11; 29(5):330-3. PubMed ID: 11093603
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T.
    Tokai J Exp Clin Med; 1993 Dec 11; 18(3-6):133-8. PubMed ID: 7701526
    [Abstract] [Full Text] [Related]

  • 19. The accuracy of the anti-α-fodrin antibody test for diagnosis of Sjögren's syndrome: a meta-analysis.
    Hu Q, Wang D, Chen W.
    Clin Biochem; 2013 Oct 11; 46(15):1372-6. PubMed ID: 23639676
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
    Folli F, Perego L, Ponzoni M, Girardi AM, Bosi E, Ferreri AJ, Bellone M, Sabbadini MG, Vicari AM, Trusolino L.
    Ann Hematol; 2002 Oct 11; 81(10):597-602. PubMed ID: 12424543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.